KAYLA RICHARDSON: Open Payments
NPI 1235681636 · CENTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,442 in 245 payments from 32 companies in 2025. Trend: 2023 $1,981 · 2024 $5,201 · 2025 $5,442
Food & beverage: $5,418Speaker / faculty: $25
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $798 |
| Lilly USA, LLC | 17 | $475 |
| UCB, Inc. | 17 | $364 |
| Amneal Pharmaceuticals LLC | 12 | $347 |
| ACADIA Pharmaceuticals Inc | 10 | $306 |
| PFIZER INC. | 21 | $279 |
| MDD US Operations, LLC | 13 | $264 |
| Novartis Pharmaceuticals Corporation | 15 | $254 |
| Neurocrine BioSciences, Inc. | 15 | $248 |
| Biogen, Inc. | 12 | $226 |
Products named: QULIPTA, CREXONT, NUPLAZID, KESIMPTA, INGREZZA, KISUNLA, NURTEC ODT, Symbravo.
Industry payments across OH — which companies pay providers there.
